ArticleBioengineering (Basel, Switzerland)2025
Machine Learning-Based Prediction of Elekta MLC Motion with Dosimetric Validation for Virtual Patient-Specific QA.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate multi-leaf collimator (MLC) motion prediction is a prerequisite for precise dose delivery in advanced techniques such as IMRT and VMAT. Traditional patient-specific quality assurance (QA) methods remain resource-intensive and prone to physical measurement uncertainties. This study aimed to develop machine learning (ML) models to predict delivered MLC positions using kinematic parameters extracted from DICOM-RT plans for the Elekta Versa HD system. A dataset comprising 200 patient plans was constructed by pairing planned MLC positions, velocities, and accelerations with corresponding delivered values parsed from unstructured trajectory logs. Four regression models, including linear regression (LR), were trained to evaluate the deterministic nature of the Elekta servo-mechanism. LR demonstrated superior prediction accuracy, achieving the lowest mean absolute error (MAE) of 0.145 mm, empirically confirming the fundamentally linear relationship between planned and delivered trajectories. Subsequent dosimetric validation using ArcCHECK measurements on 17 clinical plans revealed that LR-corrected plans achieved statistically significant improvements in gamma passing rates, with a mean increase of 2.24% under the stringent 1%/1 mm criterion (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.